What is Microbot Medical Earnings Yield (Joel Greenblatt) %?
Microbot Medical's Enterprise Value for the quarter that ended in Dec. 2023 was $13.05 Mil.
Microbot Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-10.14 Mil. Microbot Medical's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2023 was -77.52%.
The historical rank and industry rank for Microbot Medical's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
MBOT'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -156.67 Med: 3110.59 Max: 434211.44
Current: -135.14
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Microbot Medical was 434211.44%. The lowest was -156.67%. And the median was 3110.59%.
MBOT's Earnings Yield (Joel Greenblatt) % is ranked worse than 96% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: 0.17
vs MBOT: -135.14
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Microbot Medical's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Microbot Medical Earnings Yield (Joel Greenblatt) % Historical Data
The historical data trend for Microbot Medical's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Microbot Medical Earnings Yield (Joel Greenblatt) % Chart
Competitive Comparison of Microbot Medical's Earnings Yield (Joel Greenblatt) %
For the Medical Instruments & Supplies subindustry, Microbot Medical's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Microbot Medical's Earnings Yield (Joel Greenblatt) % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Microbot Medical's Earnings Yield (Joel Greenblatt) % falls into.
Microbot Medical Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Microbot Medicals Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as
Microbot Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.14 Mil.
Microbot Medical (NAS:MBOT) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Microbot Medical Earnings Yield (Joel Greenblatt) % Related Terms
Thank you for viewing the detailed overview of Microbot Medical's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
Microbot Medical (Microbot Medical) Business Description
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MBOT has been successfully added to your 